Prostate Cancer
Castration Levels of Testosterone Results in Atrophy of Androgen-Sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism.
October 22, 2024
Comparative efficacy and safety of talazoparib plus enzalutamide and other first-line treatments for metastatic castration-resistant prostate cancer.
October 22, 2024
Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial.
October 22, 2024
Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of life.
October 22, 2024
Extraperitoneal Robot-Assisted Radical Prostatectomy with the Hugo™ RAS System: Initial Experience at a High-Volume Robotic Centre.
October 21, 2024
Relugolix Plus Enzalutamide For Metastatic Hormone-Sensitive Prostate Cancer: A Case Report.
October 21, 2024
Urologic oncology case volume among early career urologists: An analysis of certification data from the American board of urology between 2003 and 2019.
October 20, 2024
Diet Quality, Dietary Inflammatory Potential, and Risk of Prostate Cancer Grade Reclassification.
October 20, 2024
Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic Review.
October 18, 2024
Targeted Prostate Health Checks, a novel system to identify men with prostate cancer-A pilot study.
October 18, 2024
Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics.
October 18, 2024